Codex DNA Inc

NASDAQ:DNAY   3:59:57 PM EDT
7.17
+0.18 (+2.58%)
Products, Strategic Combinations

Codex DNA Signs Early Access Collaboration And Licensing Agreement With Pfizer

Published: 01/10/2022 11:57 GMT
Codex DNA Inc (DNAY) - Codex Dna Signs Early Access Collaboration and Licensing Agreement With Pfizer.
Codex Dna - Financial Terms of Deal Include Upfront Payment From Pfizer, Technical Milestone Payments.
Codex Dna - Pfizer’s Successful Development & Commercialization of Licensed Products Could Result in Milestone Payments in Excess of $100 Million.
Codex Dna - Pfizer, Co Agree to Multi Year Research Collaboration, Leveraging Co’s Enzymatic Dna Synthesis (eds) Technology.